| | | | |
CUSIP No. 90064101 | | 13G/A | | Page 4 of 6 Pages |
Item 1(a). | Name of Issuer: |
uniQure N.V.
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
Paasheuvelweg 25, 1105 BP Amsterdam, The Netherlands
Item 2(a). | Name of Person Filing: |
This Statement is being filed by ForUniQure B.V. (“ForUniQure”), and Forbion 1 Management B.V. (“Forbion 1”), the director of ForUniQure. ForUniQure and Forbion 1 are sometimes referred to collectively herein as the “Reporting Persons”.
Item 2(b). | Address of Principal Business Office or, if None, Residence: |
The address of the principal business and principal office of each of the Reporting Persons is c/o Forbion Capital Partners, Gooimeer2-35, 1411 DC Naarden, The Netherlands.
ForUniQure B.V. – The Netherlands
Forbion 1 Management B.V. – The Netherlands
Item 2(d). | Title of Class of Securities: |
Common Stock, par value €0.05 per share
N90064101
ForUniQure is the beneficial owner of 4,386,742 shares of Common Stock as of February 1, 2019 (the “Shares”). ForUniQure acquired the Shares as part of an internal restructuring by Forbion Capital Partners. Forbion 1, the director of ForUniQure, has voting and investment power over the shares held by ForUniQure, which are exercised through Forbion’s investment committee, consisting of H. A. Slootweg, M. A. van Osch, G. J. Mulder and S. J. H. van Deventer. None of the members of the investment committee have individual voting and investment power with respect to such shares, and the members disclaim beneficial ownership of such shares except to the extent of their proportionate pecuniary interests therein.
| (a) | Amount beneficially owned: 4,386,742 |
| (b) | Percent of class: 11.77% |